Fundamental effects of particle morphology on lung delivery: Predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development

Pharmaceutical Research

Volumn 19, Issue 3, 2002, Pages 239-245

  Crowder, T M ^a   Rosati, J A ^b   Schroeter, J D ^a   Hickey, A J ^a   Martonen, T B ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

Aerosol(s); Density; Lung deposition; Particles; Shape; Stoke's Law

Indexed keywords

BUDESONIDE; CROMOGLYCATE DISODIUM; DRUG; FLUTICASONE; PROCATEROL; SALBUTAMOL; TERBUTALINE;

AEROSOL; DRUG DELIVERY SYSTEM; DRY DEPOSITION; DRY POWDER; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, INHALATION; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HUMANS; LUNG; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; TECHNOLOGY, PHARMACEUTICAL;

EID: 0036199308     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014426530935     Document Type: Review

References (39)

1. A new millennium for inhaler technology
2. 2001: An Odyssey in inhaler formulations and design
3. Review of dry powder inhalers
4. Medical aerosol inhalers: Past, present, and future
5. Dynamic shape factors of fractal clusters of carbonaceous smoke
6. Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols
7. Aerodynamic properties of elongated particles of cromoglycic acid
8. Recent advances in pulmonary drug delivery using large, porous inhaled particles
9. Controlled-release inhalation aerosols
10. Large porous particles for pulmonary drug delivery
11. Definitive equations for the fluid resistance of spheres
12. Shape factors for airborne particles
13. A note on the aerodynamic diameter and the mobility of non-spherical aerosol particles
14. Drag on nonspherical object
15. Growth rate measurements and deposition modeling of hygroscopic aerosols in human tracheobronchial models
16. Therapeutic uses of lung aerosols
17. Computer simulation of particle deposition in the upper tracheobronchial tree
18. Effect of gravity on aerosol dispersion and deposition in the human lung after periods of breath holding
19. Deposition of particles in the human respiratory tract in the size range 0.005-15 um
20. A model for deposition of fibers in the human respiratory system
21. Aerodynamic size classification of fibers with aerosol centrifuges
22. Disposition of disodium chromoglycate administered in three particle sizes
23. An invited review: Van der Waals and other cohesive forces affecting powder fluidization
24. Aerodynaic behavior of lipid microtubule aerosols
25. Fiber deposition in airway bifurcations
26. Factors determining hygroscopic aerosol deposition in airways
27. Analytical model of hygroscopic particle behavior in human airways
28. Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives
29. The effect of hydrophobic coating upon the behavior of a hygroscopic aerosol powder in an environment of controlled temperature and relative humidity
30. Effect of different modes of inhalation on drug delivery from a dry powder inhaler
31. In vitro evaluation of dry powder inhalers I: Drug deposition of commonly used devices
32. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers Part 2: Effect of peak flow rate (PFIR) and inspiration time on the in vitro release from three different types of commercial dry powder inhalers
33. Drug delivery characteristics of Bricanyl Turbohaler dry powder inhalers
34. Evaluation of a novel β-2 agonist dry powder inhaler formulation using the Clickhaler: An initial feasibility study